Use of artificial intelligence chatbots as a source of multiple sclerosis information: a survey of people with multiple sclerosis and healthcare professionals
Background Artificial intelligence (AI) chatbots are increasingly used to access health information, but their use for multiple sclerosis (MS)-related information among people with MS (pwMS) and healthcare professionals (HCPs) remains insufficiently characterised. This study aimed to characterise their use, factors associated with AI chatbot use, and self-reported information verification in these groups. Methods This multicentre cross-sectional study included adult pwMS and HCPs involved in their care. Data were collected using a purpose-designed survey. Results Overall, 757 pwMS (median age 45 years; 69.9% women) and 122 HCPs (median age 44.5 years; 80.3% women) participated. AI chatbots were used by 26.3% of pwMS and 39.3% of HCPs. Among pwMS, use was associated with younger age (OR = 0.96, p < 0.001) and shorter disease duration ( p = 0.002). Among HCPs, age showed opposite sex-specific associations: use decreased with age in women (OR = 0.95, p = 0.017) but non-significantly increased with age in men (OR = 1.04, p = 0.263). More than 5 years of MS-care experience was associated with non-significantly lower odds of use (OR = 0.43, p = 0.054). ChatGPT was the most frequently used chatbot among pwMS and HCPs (82.9% and 91.7%, respectively), followed by Google Gemini (34.2% and 39.6%). Rapid responses and continuous availability were the principal reasons for use. HCPs reported verifying chatbot-generated information more often than pwMS. Among pwMS, verification was associated with younger age, higher education, residence in a larger urban area, and shorter disease duration. Conclusion AI chatbots are commonly used for MS-related information by both pwMS and HCPs. Targeted education can promote critical appraisal, appropriate verification, and awareness of the limitations and risks of AI-generated health information.
Authors
- Pavel Hradílek (ORCID: https://orcid.org/0000-0001-7896-2523)
- Dana Horáková (ORCID: https://orcid.org/0000-0003-1915-0036)
- Petra Ovesná (ORCID: https://orcid.org/0000-0002-3547-5896)
- Marta Vachová (ORCID: https://orcid.org/0000-0002-8158-724X)
- Blanka Adamová (ORCID: https://orcid.org/0000-0001-8035-2687)
- Matouš Rous (ORCID: https://orcid.org/0000-0001-6282-8944)
- Iva Šrotová (ORCID: https://orcid.org/0000-0003-3912-4927)
- Sabina Vejrychová
- Eva Kubala Havrdová
- Adam Mičánek
Institutions
- University of Ostrava (CZ)
- Charles University (CZ)
- Masaryk University (CZ)
- University Hospital Brno (CZ)
- University Hospital Olomouc (CZ)
- General University Hospital in Prague (CZ)
- Palacký University Olomouc (CZ)
Publication Details
- Journal
- Frontiers in Neurology
- Published
- 2026-11-18
- DOI
- https://doi.org/10.3389/fneur.2026.1976979
- Primary Topic
- Artificial Intelligence in Healthcare and Education
- Type
- article
- Field-Weighted Citation Impact
- 0.00